Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Current Biology : CB|June 20, 2006
Polychaetoid/ZO-1 is required for cell specification and rearrangement during Drosophila tracheal morphogenesisAlain C Jung, Carlos Ribeiro, Lydia Michaut, et al.
Bioanalysis|June 25, 2014
Stability of anti-immunotherapeutic antibodies in frozen human serum samplesLydia Michaut, Nathalie Laurent, Kerstin Kentsch, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 22, 2012
Pillars article: the dorsoventral regulatory gene cassette spätzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell. 1996. 86: 973-983Bruno Lemaitre, Emmanuelle Nicolas, Lydia Michaut, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 3, 2006
Biological characterization of gene response in Rpe65-/- mouse model of Leber's congenital amaurosis during progression of the diseaseSandra Cottet, Lydia Michaut, Gaëlle Boisset, et al.
Development, Growth & Differentiation|December 14, 2011
Analyzing the function of a hox gene: an evolutionary approachLydia Michaut, Hans J Jansen, Nabila Bardine, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 26, 2003
Analysis of the eye developmental pathway in Drosophila using DNA microarraysLydia Michaut, Susanne Flister, Martin Neeb, et al.
Bioanalysis|July 2, 2026
ADA assays for high-dose biologics: redefining drug tolerance through clinical insightsManisha Saxena, David Janik, Carsten Krantz, et al.
Bioanalysis|June 25, 2014
EBF recommendation for stability testing of anti-drug antibodies; lessons learned from anti-vaccine antibody stability studiesSusanne Pihl, Lydia Michaut, Jenny Hendriks, et al.
The AAPS Journal|January 29, 2026
Industry Practices in Oligonucleotide Tissue Biodistribution Assessment: An IQ consortium Cross-Industry Survey of Current Approaches and Emerging TrendsMichael McCoy, Huaping Tang, Lydia Michaut, et al.
Molecular Therapy. Methods & Clinical Development|January 24, 2018
Nonclinical Safety Evaluation of scAAV8-<i>RLBP1</i> for Treatment of <i>RLBP1</i> Retinitis PigmentosaTimothy K MacLachlan, Mark N Milton, Oliver Turner, et al.
Pageof 2